Literature DB >> 21596729

Recursive partitioning of resistant mutations for longitudinal markers based on a U-type score.

Chengcheng Hu1, Victor Degruttola.   

Abstract

Development of human immunodeficiency virus resistance mutations is a major cause of failure of antiretroviral treatment. We develop a recursive partitioning method to correlate high-dimensional viral sequences with repeatedly measured outcomes. The splitting criterion of this procedure is based on a class of U-type score statistics. The proposed method is flexible enough to apply to a broad range of problems involving longitudinal outcomes. Simulation studies are performed to explore the finite-sample properties of the proposed method, which is also illustrated through analysis of data collected in 3 phase II clinical trials testing the antiretroviral drug efavirenz.

Entities:  

Mesh:

Year:  2011        PMID: 21596729      PMCID: PMC3169671          DOI: 10.1093/biostatistics/kxr011

Source DB:  PubMed          Journal:  Biostatistics        ISSN: 1465-4644            Impact factor:   5.899


  6 in total

1.  Characterizing the relationship between HIV-1 genotype and phenotype: prediction-based classification.

Authors:  A S Foulkes; Gruttola V De
Journal:  Biometrics       Date:  2002-03       Impact factor: 2.571

2.  Diversity and complexity of HIV-1 drug resistance: a bioinformatics approach to predicting phenotype from genotype.

Authors:  Niko Beerenwinkel; Barbara Schmidt; Hauke Walter; Rolf Kaiser; Thomas Lengauer; Daniel Hoffmann; Klaus Korn; Joachim Selbig
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-11       Impact factor: 11.205

3.  Nonparametric tests for two-group comparisons of dependent observations obtained at varying time points.

Authors:  Susanne May; Victor Degruttola
Journal:  Biometrics       Date:  2007-03       Impact factor: 2.571

Review 4.  Update of the drug resistance mutations in HIV-1: December 2009.

Authors:  Victoria A Johnson; Francoise Brun-Vezinet; Bonaventura Clotet; Huldrych F Gunthard; Daniel R Kuritzkes; Deenan Pillay; Jonathan M Schapiro; Douglas D Richman
Journal:  Top HIV Med       Date:  2009-12

5.  Human immunodeficiency virus type 1 mutations selected in patients failing efavirenz combination therapy.

Authors:  L T Bacheler; E D Anton; P Kudish; D Baker; J Bunville; K Krakowski; L Bolling; M Aujay; X V Wang; D Ellis; M F Becker; A L Lasut; H J George; D R Spalding; G Hollis; K Abremski
Journal:  Antimicrob Agents Chemother       Date:  2000-09       Impact factor: 5.191

6.  Methods for investigation of the relationship between drug-susceptibility phenotype and human immunodeficiency virus type 1 genotype with applications to AIDS clinical trials group 333.

Authors:  A D Sevin; V DeGruttola; M Nijhuis; J M Schapiro; A S Foulkes; M F Para; C A Boucher
Journal:  J Infect Dis       Date:  2000-07-06       Impact factor: 5.226

  6 in total
  1 in total

1.  Recursive partitioning for monotone missing at random longitudinal markers.

Authors:  Shannon Stock; Victor DeGruttola
Journal:  Stat Med       Date:  2012-09-02       Impact factor: 2.373

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.